NDC 68071-2299-03 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-2299
- Requested NDC
- 68071-2299-03
- Package NDCs from labels
- 68071-2299-3, 68071-2299-03
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-07-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2299-3 | Acyclovir | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2299 | ACYCLOVIR CAPSULE [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240719_b455053f-3deb-bd76-e053-2a95a90a9869.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | Carlsbad Technology, Inc. | a68e610a-841c-4b69-9233-673d060561e8 | 2024-08-26 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Carlsbad Technology, Inc. | 37499620-6a17-40f1-b0db-dd79320ea21d | 2024-08-26 | Warnings, Adverse reactions | ANDA206261 61442-114 197310 209d3e94-5d8e-8799-e063-6394a90ab9d1 37499620-6a17-40f1-b0db-dd79320ea21d X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | c46d5033-b1b2-e213-e053-2995a90ae6a3 | 2024-08-22 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals, Inc. | 40e5cc54-ed74-3369-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | bb956f2b-627a-49bd-b258-4aac21d64b9a | 2024-08-14 | X4HES1O11F | |
| acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | fdf6b492-a76e-4cea-89a1-a5b19c7938ff | 2024-08-14 | X4HES1O11F | |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | a7fd298b-3914-4316-8484-2d3ae188221a | 2024-08-12 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | ada4004a-c10a-6190-e053-2a95a90a5e67 | 2024-07-17 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | b1b999a9-11cc-d6e5-e053-2995a90a5478 | 2024-07-17 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | b2ae0432-bd2a-1480-e053-2a95a90a6fc8 | 2024-07-17 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | b455053f-3deb-bd76-e053-2a95a90a9869 | 2024-07-17 | Warnings, Adverse reactions | ANDA206261 68071-2299-3 68071-2299 68071229903 197310 1d785fd9-da01-92dd-e063-6294a90a9c1a b455053f-3deb-bd76-e053-2a95a90a9869 X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 638803d2-a172-486d-e053-2991aa0ab074 | 2024-07-16 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 968800dc-9456-a45f-e053-2995a90aa15e | 2024-06-19 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 67a7ab8b-4b85-4f7b-8ae0-3dcdc273ed69 | 2024-06-18 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | bf1b4142-c5f3-4147-8224-bf6344566694 | 2024-05-30 | Warnings, Adverse reactions | X4HES1O11F |
| Enviroclenz | BERBERIS VULGARIS, CARDUUS MARIANUS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, STILLINGIA SYLVATICA, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, GERMANIUM SESQUIOXIDE, PHYTOLACCA DECANDRA, ACETONE, AMMONIUM MURIATICUM, BENZINUM, PROPYLENE GLYCOL, SODIUM LAURYL SULFATE, SODIUM TRIPOLYPHOSPHATE, TEREBINTHINA, METHANOL, CHLORINUM, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM | Deseret Biologicals, Inc. | 92816bbe-96d6-45fc-9929-d3e6df394a33 | 2024-05-02 | Warnings | 368GB5141J |
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | c0e41bf9-e141-404e-9952-aeeb705958b4 | 2024-04-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | e73ae5c8-7a77-4330-817d-482d1de4e994 | 2024-04-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Padagis Israel Pharmaceuticals Ltd | 63fadf54-e8a3-4512-8a05-d64b998f5a08 | 2024-03-31 | Warnings, Adverse reactions | X4HES1O11F |
| Envirotox | TRITICUM AESTIVUM, BERBERIS VULGARIS, LAPPA MAJOR, RHAMNUS PURSHIANA, SENNS (CASSIA ANGUSTIFOLIA), PHYTOLACCA DECANDRA, GLYCYRRHIZA GLABRA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, ACETONUM ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM. | BioActive Nutritional, Inc. | 2b5cfdba-cf4d-4eb0-8c60-20eac6922663 | 2024-03-26 | Warnings | 368GB5141J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.